T1	Participants 55 62	elderly
T2	Participants 122 142	100 elderly patients
T3	Participants 122 282	100 elderly patients with signs of cerebro-vascular impairment demonstrated by psychometric testing that Hydergine (an ergot alkaloid preparation: 4.5 mg daily)
